PDS-0101

N/A

Report date: 2025/03/19 11:14:15

Base Information

Drug NamePDS-0101
Drug Alias NameVersamune-HPVPDS-0101BPDS-0101CPDS-0101PDS-0101A +[6] 
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionCD8-positive T-Lymphocytes stimulantsCD4-positive T-lymphocytes stimulantsInterferon gamma stimulants +[4] 
TargetsInterferon gamma
Therapy Area/IndicationsVulvar NeoplasmsUterine Cervical NeoplasmsOropharyngeal Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoIreland +[4] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPds Biotechnology Corp
China Registration ClassN/A

Develop Information

Active CompaniesFarmacoreWeill Medical College of Cornell UniversityPds Biotechnology Corp +[5] 
Inactive CompaniesN/A
Active IndicationsVulvar NeoplasmsUterine Cervical NeoplasmsOropharyngeal Neoplasms +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A